Perrigo | PRGO - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
AbbVie USD 3.63B 54M 2026-06
Abbott USD 3.6B 330M 2026-06
Bayer EUR 3.96B 267M 2026-06
Bristol-Myers Squibb USD 1.83B 209M 2026-06
Coherus Biosciences USD 15M 6.26M 2025-12
Corcept Therapeutics USD 156.9M 28.85M 2026-06
Dr.Reddys Laboratories INR 26.1B 11.63B 2026-06
Eli Lilly USD 3.43B 496M 2026-06
J&J USD 6.42B 381M 2026-06
Merck USD 2.89B 219M 2026-06
Nestle CHF 12.33B 133M 2026-06
Pacira USD 91.81M 7.93M 2026-06
Perrigo USD 3.28B 3.02B 2026-06
Pfizer USD 3.41B 496M 2026-06
Phibro Animal Health USD 78.32M 10.24M 2025-12
Prestige Brands USD 43.3M 13.02M 2026-06
Sanofi EUR 2.63B 307M 2026-06
Supernus Pharmaceuticals USD 133.64M 15.41M 2026-06
Teva Pharmaceutical Industries USD 1.03B 34M 2026-06
Xeris Pharmaceuticals USD 53.14M 10.51M 2026-03
Zoetis USD 592M 4M 2026-06